Click on a filter below to refine your search. Remove a filter to broaden your search.
A lower diligence level was linked to the risk for new cardiovascular disease, but a healthy lifestyle still was beneficial.
The estimated percentage eligible ranges from 24 to 62% depending on the eligibility criteria used.
The findings were seen despite similar use of emergency medical services transport.
AF patients became relatively younger over time, were less likely to be female or White, and were more likely to have HTN, diabetes
Wegovy, Zepbound and other cutting-edge weight-loss drugs are in short supply and often too expensive to afford without insurance coverage.
The medication already was approved for advanced disease.
Over several years, lower all-cause mortality and major adverse cardiovascular events can be seen.
The findings were independent of energy intake and based on an eight-hour eating window, regardless of time of day.
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.
Accuracies were up to 84 percent for women and 77 percent for men using HTN threshold of SBP ≥135 mmHg and DBP ≥85 mmHg